Design of LTCC-based Ceramic Structure for Chemical Microreactor

The design of ceramic chemical microreactor for the production of hydrogen needed in portable polymer-electrolyte membrane (PEM) fuel cells is presented. The microreactor was developed for the steam reforming of liquid fuels with water into hydrogen. The complex three-dimensional ceramic structure of the microreactor includes evaporator(s), mixer(s), reformer and combustor. Low-temperature co-fired ceramic (LTCC) technology was used to fabricate the ceramic structures with buried cavities and channels, and thick-film technology was used to make electrical heaters, temperature sensors and pressure sensors. The final 3D ceramic structure consists of 45 LTCC tapes. The dimensions of the structure are 75 × 41 × 9 mm3 and the weight is about 73 g

Effects of LiDAR data reduction and breaklines on the accuracy of digital elevation model

This paper explores the effects of LiDAR data reduction on the accuracies of produced TINs and gridded DEMs. It examined to what extent a set of LiDAR (light detection and ranging) data can be reduced without sacrificing the accuracy of produced terrain model. A primary focus was on the integration of breaklines to the reduction process to assess the contribution of breaklines to improving the accuracy of terrain models in data reduction. A series of TINs and gridded DEMs were produced and assessed at reduced data density levels with and without breaklines respectively. The results showed that LiDAR data can be reduced to a certain level without significantly decreasing the accuracy of produced terrain models. When incorporating breaklines into terrain modelling, the accuracy of produced TINs and gridded DEMs decreased only slightly as data density decreased, indicating that breaklines made a significant contribution to improving the accuracy of terrain models in data reduction

Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

Aims: Our aim was to report on a survey initiated by the EuropeanAssociation of Percutaneous Cardiovascular Interventions (EAPCI) concerning opinion on the evidence relating to dual antiplatelet therapy (DAPT) duration after coronary stenting.Methods and results: Results from three randomised clinical trials were scheduled to be presented at the American Heart Association Scientific Sessions 2014 (ARIA 2014). A web-based survey was distributed to all individuals registered in the EuroIntervention mailing list (n=15,200) both before and after ARIA 2014. A total of 1,134 physicians responded to the first (i.e., before AHA 2014) and 542 to the second (i.e., after ARIA 2014) survey. The majority of respondents interpreted trial results consistent with a substantial equipoise regarding the benefits and risks of an extended versus a standard DAPT strategy. Two respondents out of ten believed extended DAFT should be implemented in selected patients. After ARIA 2014, 46.1% of participants expressed uncertainty about the available evidence on DAFT duration, and 40.0% the need for clinical guidance.Conclusions: This EAPCI survey highlights considerable uncertainty within the medical community with regard to the optimal duration of DAFT after coronary stenting in the light of recent reported trial results. Updated recommendations for practising physicians to guide treatment decisions in routine clinical practice should be provided by international societies